Pancreatic Adenocarcinoma | Norton Healthcare

Indication: Pancreatic Adenocarcinoma

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Sub-indication: Pancreatic Adenocarcinoma

Study Type: Drug Study

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: Sponsor: Bristol-Myers Squibb (BMS)

Learn more at

Email for more information:

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.